Cancer Vaccines Market to Exceed USD 19.12 Billion by 2029, with a 14.7% CAGR

The global cancer vaccines market was valued at USD 6.43 billion in 2021 and is expected to grow at a CAGR of 14.7% from USD 7.32 billion in 2022 to USD 19.12 billion by 2029. During the forecast period, the market is expected to grow at a ...

WHO Introduces Online Repository of Evidence-informed Decision-making Tools

The first of its kind, the WHO online repository of evidence-informed decision-making (EIDM) tools highlights WHO tools as well as external tools used by WHO to facilitate knowledge translation and partner organizations involved in the process....

India and Germany Partners to Bridge Healthcare Worker Gap

Indo-Euro Synchronisation (IES) has announced the groundbreaking event 'Upskilling Certification Linked to Nursing Employment in Germany' in order to foster collaborations between Germany and India. This event acted as a catalyst, highlighting...

Pyxis Oncology Completes its Acquisition of Clinical-stage Biopharma Company, Apexigen

Pyxis Oncology, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative antibody therapeutics for oncology, announced the successful completion of its acquisition of Apexigen, Inc. (Apexigen),...

Exploring Collaborations with Govts & NGOs can Expand access to Essential Medicines says Sunil Attavar

Indian pharmaceutical manufacturers will need to explore partnerships with governments and NGOs (non-governmental organisations) to expand access to essential medicines, according to Sunil Attavar, former president of the Karnataka Drugs...

Mizoram Becomes Second State in the North East to announce PPR 2015

Following in the footsteps of Nagaland, the Government of Mizoram in the country's north-east has notified the Pharmacy Practise Regulations (PPR) 2015, which rigorously demand that only licenced chemists can administer pharmaceuticals...

Agilus Diagnostics announced Opening of Advanced Laboratory in Panjagutta, Hyderabad

Agilus Diagnostics, a Fortis Healthcare Limited subsidiary, announced the opening of a new laboratory in Panjagutta. The sophisticated laboratory can process 60,000+ samples per month, ranging from simple routine tests to semi-specialized...

New R&D Policy can Unlock India's Huge Research & Innovation Potential says Kiran Mazumdar Shaw

The central government's recently released National Policy on Research and Development and Innovation in the Pharma-MedTech Sector, according to Kiran Mazumdar-Shaw, executive chairperson of Biocon and Biocon Biologics, could be a game changer...

Gujarat FDCA's m-governance Programme to be Launched out soon as all three phases of Safety Audit conclude

The Gujarat Food and Drug Control Administration (FDCA)’s flagship m-governance programme will soon see the light of the day as all three phases of safety audit have been concluded to benefit 55,600 stakeholders in the state including the 3,800....

Vadodara-based Shiva Pharmachem files DRHP for its Rs. 900 crore IPO

Shiva Pharmachem, the largest manufacturer of acid and alkyl chlorides, by volume, in CY 2022 in India and a key player globally, with over 2 decades of experience in the Indian specialty chemicals business has filed...

© 2024 India Pharma Outlook. All Rights Reserved.